o
oxycodone
Analgesic alkaloid (opioid)
Also known as dihydroxycodeinone · dihydrohydroxycodeinone · dihydro-14-hydroxycodeinone · 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one · 4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one · (-)-14-hydroxydihydrocodeinone
- Formula
- C₁₈H₂₁NO₄
1
- C₁₈H₂₁NO₄
- Mass
- 315.147 Da
1
- 315.147 Da
Overview
Chemistry
All data
232 statements · 70% with external sources · numbers in brackets are citations
- Medical condition treated
- pain
2
Sources- 1.Stated in NDF-RTRetrieved 2016-12-13
- 2.latimes.com/projects/oxycontin-part1/Retrieved 2016-12-20
- substance abuse
1
Sources- 1.Stated in Drug Indications Extracted from FAERSRetrieved 2018-10-02
- fibromyalgia
1
Sources- 1.Stated in Drug Indications Extracted from FAERSRetrieved 2018-10-02
- injury
1
Sources- 1.Stated in Drug Indications Extracted from FAERSRetrieved 2018-10-02
- pain
- Isomeric SMILES
- CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O
1
- CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O
- Canonical SMILES
- CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O
1
- CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O
- Discovered
- 1916 location: Goethe University Frankfurt
- Stylized name
- oxyCODONE has characteristic: Tall Man lettering · issued by: Institute for Safe Medication Practices
1
Sources- 1.ismp.org/recommendations/tall-man-letters-listRetrieved 2022-09-02
- OxyCONTIN has characteristic: Tall Man lettering · issued by: Institute for Safe Medication Practices
1
Sources- 1.ismp.org/recommendations/tall-man-letters-listRetrieved 2022-09-02
- oxyCODONE has characteristic: Tall Man lettering · issued by: Institute for Safe Medication Practices
- Defined daily dose
- 75 milligram route of administration: oral administration
- 30 milligram route of administration: parenteral route of administration
- Legal status (medicine)
- boxed warning
1
Sources- 1.“FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.”nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802
- boxed warning
- Significant drug interaction
- pethidine side effect: depressed level of consciousness
- pethidine side effect: central respiratory depression
- tramadol side effect: depressed level of consciousness
- tramadol side effect: central respiratory depression
- buprenorphine side effect: depressed level of consciousness
- buprenorphine side effect: central respiratory depression
- tapentadol side effect: depressed level of consciousness
- tapentadol side effect: central respiratory depression
Show 52 moreShow less
- sufentanil side effect: depressed level of consciousness
- sufentanil side effect: central respiratory depression
- (RS)-methadone side effect: depressed level of consciousness
- (RS)-methadone side effect: central respiratory depression
- morphine side effect: depressed level of consciousness
- morphine side effect: central respiratory depression
- hydromorphone side effect: depressed level of consciousness
- hydromorphone side effect: central respiratory depression
- fentanyl side effect: depressed level of consciousness
- fentanyl side effect: central respiratory depression
- codeine side effect: depressed level of consciousness
- codeine side effect: central respiratory depression
- remifentanil side effect: depressed level of consciousness
- remifentanil side effect: central respiratory depression
- dihydrocodeine side effect: depressed level of consciousness
- dihydrocodeine side effect: central respiratory depression
- alfentanil side effect: depressed level of consciousness
- alfentanil side effect: central respiratory depression
- periciazine side effect: depressed level of consciousness
- levomepromazine side effect: depressed level of consciousness
- levomepromazine side effect: central respiratory depression
- trimeprazine side effect: depressed level of consciousness
- trimeprazine side effect: central respiratory depression
- nitrazepam side effect: depressed level of consciousness
- nitrazepam side effect: central respiratory depression
- zopiclone side effect: depressed level of consciousness
- zopiclone side effect: central respiratory depression
- clobazam side effect: depressed level of consciousness
- clobazam side effect: central respiratory depression
- periciazine side effect: central respiratory depression
- dexmedetomidine side effect: depressed level of consciousness
- dexmedetomidine side effect: central respiratory depression
- (RS)-sulpiride side effect: depressed level of consciousness
- (RS)-sulpiride side effect: central respiratory depression
- perampanel side effect: depressed level of consciousness
- perampanel side effect: central respiratory depression
- (±)-thiopental side effect: depressed level of consciousness
- (±)-thiopental side effect: central respiratory depression
- midazolam side effect: depressed level of consciousness
- midazolam side effect: central respiratory depression
- (RS)-baclofen side effect: depressed level of consciousness
- (RS)-baclofen side effect: central respiratory depression
- diazepam side effect: depressed level of consciousness
- diazepam side effect: central respiratory depression
- oxazepam side effect: depressed level of consciousness
- oxazepam side effect: central respiratory depression
- droperidol side effect: depressed level of consciousness
- droperidol side effect: central respiratory depression
- zolpidem side effect: depressed level of consciousness
- zolpidem side effect: central respiratory depression
- flurazepam side effect: depressed level of consciousness
- flurazepam side effect: central respiratory depression
- Substance control status
- Schedule II (Russia) applies to jurisdiction: Russia
1
Sources- 1.Stated in Government Decree No. 681 of 30 June 1998 (Russia)consultant.ru/document/cons_doc_LAW_19243/Retrieved 2026-08-31
- Schedule 8 (Australia) applies to jurisdiction: Australia
- Schedule I (Canada) applies to jurisdiction: Canada
- Anlage III (Germany) applies to jurisdiction: Germany
- Class A (United Kingdom) applies to jurisdiction: United Kingdom
- Schedule II (United States) applies to jurisdiction: United States
- Schedule I (Single Convention 1961)
- Schedule II (Russia) applies to jurisdiction: Russia
On other databases
59 identifiers linking oxycodone across the web's reference databases
- ATC codeN02AA05
- BBC Things ID164f16fc-cbaf-4227-b97a-fc8b9ab219c6
- CAS Registry Number76-42-6
- ChEBI ID7852
- ChEMBL IDCHEMBL656
- ChemSpider ID4447649
- DrugBank IDDB00497
- DrugCentral ID2029
- DSSTOX compound identifierDTXCID903407
- DSSTox substance IDDTXSID5023407
- EC number200-960-2
- ECHA Substance Infocard ID100.000.874
- Electronic Essential Medicines List medicine ID559
- Encyclopædia Britannica Online IDscience/oxycodone
- Freebase ID/m/05q1y
- GND ID4255826-8
- Guide to Pharmacology Ligand ID7093
- Harper's tagoxycontin
- HSDB ID3142
- Human Metabolome Database IDHMDB0014640
- InChIInChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1
- InChIKeyBRUQQQPBMZOVGD-XFKAJCMBSA-N
- J9U entity ID987007544676905171
- KBpedia IDOxycodone
- KEGG IDC08018
- KNApSAcK IDC00052375
- Library of Congress Authorities IDsh2002006018
- MassBank accession IDMSBNK-Athens_Univ-AU160201
- MedlinePlus drug identifiera682132
- MeSH concept IDM0015664
- MeSH descriptor IDD010098
- MeSH tree codeD03.132.577.249.562.149.575
- Microsoft Academic ID (discontinued)2776029756
- NDF-RT IDN0000147955
- New York Times topic IDsubject/oxycontin-drug
- NSC number19043
- Online PWN Encyclopedia ID3950599
- OpenAlex IDC2776029756
- PatientsLikeMe treatment IDoxycodone
- PDB ligand IDOOX
- Probes And Drugs IDPD009992
- PubChem CID5284603
- Quora topic IDOxycodone
- Reaxys registry number43446
- Römpp online IDRD-15-01324
- RxNorm CUI7804
- SPLASHsplash10-00kb-0095000000-83c78e9e15857145cc78
- Store medisinske leksikon IDoksykodon
- SureChEMBL ID2737
- UK Parliament thesaurus ID561122
- UMLS CUIC0030049
- UniChem compound ID364697
- UNIICD35PMG570
- UNSPSC code51142207
- Wellcome Collection concept IDvwzd6vjq
- WikiKids IDOxycodon
- WikiProjectMed IDOxycodone
- Yale LUX IDconcept/f49b30a9-244c-4243-976b-035cdd8322fa
- YSO ID21402